AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 152 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $20,089,000 | -6.8% | 964,906 | 0.0% | 0.14% | -9.8% |
| Q1 2019 | $21,565,000 | -6.6% | 964,906 | 0.0% | 0.15% | -21.5% |
| Q4 2018 | $23,080,000 | -12.3% | 964,906 | 0.0% | 0.20% | +3.2% |
| Q3 2018 | $26,322,000 | +1.4% | 964,906 | 0.0% | 0.19% | -7.4% |
| Q2 2018 | $25,946,000 | -9.3% | 964,906 | 0.0% | 0.20% | -8.1% |
| Q1 2018 | $28,609,000 | -51.4% | 964,906 | -38.0% | 0.22% | -64.5% |
| Q4 2017 | $58,838,000 | – | 1,555,734 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|